Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) Short Interest Update

Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) saw a large drop in short interest in the month of June. As of June 30th, there was short interest totaling 191,938 shares, a drop of 35.0% from the June 15th total of 295,188 shares. Based on an average trading volume of 20 shares, the short-interest ratio is currently 9,596.9 days. Approximately 0.1% of the shares of the stock are sold short.

Recordati Industria Chimica E Farmaceutica Stock Performance

Recordati Industria Chimica E Farmaceutica stock opened at $58.00 on Friday. Recordati Industria Chimica E Farmaceutica has a 12 month low of $55.88 and a 12 month high of $60.00. The company has a market cap of $11.97 billion, a price-to-earnings ratio of 21.94 and a beta of 0.25. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.26 and a quick ratio of 0.86. The stock’s 50-day moving average is $58.33 and its 200-day moving average is $59.87.

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) last announced its quarterly earnings results on Wednesday, May 13th. The company reported $1.08 earnings per share for the quarter. Recordati Industria Chimica E Farmaceutica had a return on equity of 34.38% and a net margin of 17.81%.The business had revenue of $834.86 million for the quarter.

About Recordati Industria Chimica E Farmaceutica

Recordati Industria Chimica e Farmaceutica is an Italy‐based international pharmaceutical company engaged in the research, development, manufacturing and commercialization of therapeutic products. Established in 1926, the company has built a diversified portfolio that includes proprietary drugs, generics and orphan medicines, with a particular emphasis on treatments for rare diseases. Recordati’s product range spans cardiovascular, urology, endocrinology, dermatology and oncology therapies, as well as specialized formulations for genetic and metabolic disorders.

The company’s historical roots date back nearly a century, when it began as a family‐owned enterprise in Milan.